Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Plerixafor Injection

Approval Number

国药准字HJ20200037

CompanySanofi B.V.

Registration Date

May 16, 2023

Drug Information

Generic Name

普乐沙福注射液

Trade Name

释倍灵

Dosage Form

注射剂

Strength

1.2ml:24mg

Drug Type

化学药品

Registration Date

May 16, 2023

Expiry Date

May 15, 2028

Company Information

Applicant Company

Company NameSanofi B.V.

Company Address

Paasheuvelweg 25,1105 BP Amsterdam,The Netherlands

Manufacturing Company

Company NameGENZYME CORPORATION

Company Address

1125 Pleasant View Terrace,Ridgefield,NJ 07657,United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

普乐沙福注射液 - NMPA 批准文号 | MedPath